1. Home
  2. OBDE vs LMAT Comparison

OBDE vs LMAT Comparison

Compare OBDE & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBDE
  • LMAT
  • Stock Information
  • Founded
  • OBDE 2020
  • LMAT 1983
  • Country
  • OBDE United States
  • LMAT United States
  • Employees
  • OBDE N/A
  • LMAT N/A
  • Industry
  • OBDE
  • LMAT Medical/Dental Instruments
  • Sector
  • OBDE
  • LMAT Health Care
  • Exchange
  • OBDE NYSE
  • LMAT Nasdaq
  • Market Cap
  • OBDE 1.8B
  • LMAT 2.0B
  • IPO Year
  • OBDE N/A
  • LMAT 2006
  • Fundamental
  • Price
  • OBDE $14.55
  • LMAT $89.08
  • Analyst Decision
  • OBDE Buy
  • LMAT Buy
  • Analyst Count
  • OBDE 1
  • LMAT 6
  • Target Price
  • OBDE $16.00
  • LMAT $92.60
  • AVG Volume (30 Days)
  • OBDE 180.0K
  • LMAT 98.3K
  • Earning Date
  • OBDE 11-06-2024
  • LMAT 10-31-2024
  • Dividend Yield
  • OBDE 4.03%
  • LMAT 0.72%
  • EPS Growth
  • OBDE N/A
  • LMAT 47.83
  • EPS
  • OBDE N/A
  • LMAT 1.67
  • Revenue
  • OBDE N/A
  • LMAT $205,621,000.00
  • Revenue This Year
  • OBDE N/A
  • LMAT $15.01
  • Revenue Next Year
  • OBDE N/A
  • LMAT $9.07
  • P/E Ratio
  • OBDE N/A
  • LMAT $54.11
  • Revenue Growth
  • OBDE N/A
  • LMAT 16.06
  • 52 Week Low
  • OBDE $13.60
  • LMAT $45.96
  • 52 Week High
  • OBDE $16.80
  • LMAT $93.32
  • Technical
  • Relative Strength Index (RSI)
  • OBDE 55.89
  • LMAT 55.00
  • Support Level
  • OBDE $14.16
  • LMAT $84.69
  • Resistance Level
  • OBDE $14.65
  • LMAT $92.84
  • Average True Range (ATR)
  • OBDE 0.20
  • LMAT 2.05
  • MACD
  • OBDE 0.01
  • LMAT -0.07
  • Stochastic Oscillator
  • OBDE 80.33
  • LMAT 75.21

About OBDE BLUE OWL CAPITAL CORP III

Blue Owl Capital Corp III is focused on originating and making loans to, and debt and equity investments in middle-market companies based predominantly in the United States. Its objective is to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns. The company invests in senior secured or unsecured loans, subordinated loans or mezzanine loans and, to a lesser extent, equity and equity-related securities including warrants, preferred stock and similar forms of senior equity, which may or may not be convertible into a portfolio company's common equity.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

Share on Social Networks: